Medtronic (NYSE:MDT) said the FDA granted 510(k) clearance for its Affinity Fusion blood oxygenator, used during open heart surgery to replace the function of the lungs.
The Minneapolis-area medical device company, which is the world’s largest pure-play medtech maker, said the Affinity Fusion is designed to filter a patient’s blood to remove particles and air during oxygenation.